Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15;226(Suppl 2):S184-S194.
doi: 10.1093/infdis/jiac155.

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019

Mina Suh  1 , Naimisha Movva  1 , Xiaohui Jiang  1 , Heidi Reichert  1 , Lauren C Bylsma  1 , Jon P Fryzek  1 , Christopher B Nelson  2
Affiliations

Respiratory Syncytial Virus Burden and Healthcare Utilization in United States Infants <1 Year of Age: Study of Nationally Representative Databases, 2011-2019

Mina Suh et al. J Infect Dis. .

Abstract

Background: Respiratory syncytial virus (RSV) is the leading cause of hospitalizations in United States infants aged <1 year, but research has focused on select populations.

Methods: National (Nationwide) Inpatient Sample and National Emergency Department (ED) Sample data (2011-2019) were used to report RSV hospitalization (RSVH), bronchiolitis hospitalization (BH), and ED visit counts, percentage of total hospitalizations/visits, and rates per 1000 live births along with inpatient mortality, mechanical ventilation (MV), and total charges (2020 US dollars).

Results: Average annual RSVH and RSV ED visits were 56 927 (range, 43 845-66 155) and 131 999 (range, 89 809-177 680), respectively. RSVH rates remained constant over time (P = .5), whereas ED visit rates increased (P = .004). From 2011 through 2019, Medicaid infants had the highest average rates (RSVH: 22.3 [95% confidence interval {CI}, 21.5-23.1] per 1000; ED visits: 55.9 [95% CI, 52.4-59.4] per 1000) compared to infants with private or other/unknown insurance (RSVH: P < .0001; ED visits: P < .0001). From 2011 through 2019, for all races and ethnicities, Medicaid infants had higher average RSVH rates (up to 7 times) compared to infants with private or other/unknown insurance. RSVH mortality remained constant over time (P = .8), whereas MV use (2019: 13% of RSVH, P < .0001) and mean charge during hospitalization (2019: $21 513, P < .0001) increased. Bronchiolitis patterns were similar.

Conclusions: This study highlights the importance of ensuring access to RSV preventive measures for all infants.

Keywords: Medicaid; RSV; RSV hospitalizations; birth month; bronchiolitis hospitalizations; emergency department; infants; respiratory syncytial virus.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. EpidStrategies received a grant from Sanofi for this research. M. S., N. M., X. J., H. R., L. C. B., and J. P. F. are employees of EpidStrategies. C. B. N. is an employee of Sanofi and may hold shares and/or stock options in the company. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Figures

Figure 1.
Figure 1.
Respiratory syncytial virus (RSV) (A) and bronchiolitis (B) hospitalization proportions and rates per 1000 live births by admission year, United States infants aged <1 year, National (Nationwide) Inpatient Sample, 2011–2019. To calculate proportions (%), the total number of infant hospitalizations in that year was used as the denominator. RSV and bronchiolitis were defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0); bronchiolitis (RSV codes plus unspecified bronchiolitis: ICD-9: 079.6, 466.11, 466.19, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0, J21.8, J21.9). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX).
Figure 2.
Figure 2.
Respiratory syncytial virus (RSV) (A) and bronchiolitis (B) emergency department (ED) visit burden proportions and rates per 1000 live births by admission year, United States infants aged <1 year, Nationwide Emergency Department Sample, 2011–2019. To calculate proportions (%), the total number of infant ED visits in that year was used as the denominator. RSV and bronchiolitis were defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0); bronchiolitis (RSV codes plus unspecified bronchiolitis: ICD-9: 079.6, 466.11, 466.19, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0, J21.8, J21.9). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX).
Figure 3.
Figure 3.
Respiratory syncytial virus (RSV) hospitalization rates per 1000 live births by insurance payer and race/ethnicity, United States infants aged <1 year, National (Nationwide) Inpatient Sample, 2011–2019. RSV was defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX). Abbreviations: AI/AN, American Indian/Alaska Native; API, Asian and Pacific Islander; NH, non-Hispanic; RSV, respiratory syncytial virus.
Figure 4.
Figure 4.
Respiratory syncytial virus (RSV) (A) and bronchiolitis (B) emergency department (ED) visit proportions and rates per 1000 live births by insurance payer, United States infants aged <1 year, Nationwide Emergency Department Sample, 2011–2019. To calculate proportions (%), the total number of RSV or bronchiolitis ED visits was used as the denominator. RSV and bronchiolitis were defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0); bronchiolitis (RSV codes plus unspecified bronchiolitis: ICD-9: 079.6, 466.11, 466.19, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0, J21.8, J21.9). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX).
Figure 5.
Figure 5.
Respiratory syncytial virus (RSV) hospitalization rates per 1000 live births by birth month, United States infants aged <1 year, National (Nationwide) Inpatient Sample, 2011. Birth month was available only in 2011. RSV was defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX).
Figure 6.
Figure 6.
Respiratory syncytial virus (RSV) as a proportion of total infant hospitalizations by age (in months) and by admission month, United States infants aged <1 year, National (Nationwide) Inpatient Sample, 2011. Age was available only in 2011. Proportions (%) in each cell were calculated using the total number of infant hospitalizations for chronological age and during each admission month as the denominator. Example interpretation: Of all infants aged 1 month and admitted to the hospital in January, 34.7% were hospitalized due to RSV. RSV was defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX). Sample sizes ≤10 were not reported, in accordance with the Agency for Healthcare Research and Quality's Healthcare Cost and Utilization Project.
Figure 7.
Figure 7.
Mechanical ventilation (MV) proportions among respiratory syncytial virus (RSV) hospitalizations by insurance payer and race/ethnicity, United States infants aged <1 year, National (Nationwide) Inpatient Sample, 2011–2018. To calculate proportions (%), the total number of infant RSV hospitalizations regardless of MV use for that insurance payer and race/ethnicity was used as the denominator. RSV was defined by International Classification of Diseases, Ninth and Tenth Revision (ICD-9 and ICD-10) diagnosis codes: RSV (ICD-9: 079.6, 466.11, 480.1; ICD-10: B97.4, J12.1, J20.5, J21.0). Excludes newborn birth hospitalizations (ICD-9: V30.XX–V39.XX; ICD-10: Z38.XX). Abbreviations: AI/AN, American Indian/Alaska Native; API, Asian and Pacific Islander; MV, mechanical ventilation; NH, non-Hispanic; RSV, respiratory syncytial virus.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Suh M, Movva N, Jiang X, et al. . Respiratory syncytial virus is the leading cause of United States infant hospitalizations, 2009–2019: a study of the National (Nationwide) Inpatient Sample. J Infect Dis 2022; 226(S2):S154–63. - PMC - PubMed
    1. Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143:S127–32. - PubMed
    1. Holman RC, Curns AT, Cheek JE, et al. . Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics 2004; 114:e437–44. - PubMed
    1. Yorita KL, Holman RC, Sejvar JJ, Steiner CA, Schonberger LB. Infectious disease hospitalizations among infants in the United States. Pediatrics 2008; 121:244–52. - PubMed
    1. Ledbetter J, Brannman L, Wade SW, Gonzales T, Kong AM. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants. J Med Econ 2020; 23:139–47. - PubMed

Publication types